Click on title for full press release
Funding supports continued commercial expansion, clinical evidence generation, and ongoing innovation across the CVAC System platform Read More.
Two‑year health economics analysis shows that reducing residual stone burden with the CVAC System lowers follow-up healthcare costs by 64%, saving an average of $3,464 per patient. Read More.
Findings reinforce a new, patient-centered standard for assessing efficacy of stone removal procedures and demonstrate significant reduction in downstream healthcare events. Read More.
Joe Catanese, Ph.D., Chief Executive Officer of Calyxo will present on Monday, January 12, 2026, at 8:30 AM PT in San Francisco, CA. Read More.
Dana G. Mead, Jr. brings 30 years of expertise in product strategy, development and commercialization to the Calyxo boardroom, as the company marks its next stage of growth. Read More.
Launch of Reverse Deflection on Calyxo’s second-generation CVAC System promises endourologists greater intuitiveness and control in kidney stone procedures. Read More.
Real-world data demonstrate the efficacy of the CVAC System across varied clinical settings, showing significant reductions in absolute stone volume and fewer complications compared to the flexible and navigable ureteric access sheath (FANS). Clinical studies further validate the safety profile of the CVAC System. Read More.
Eight accepted abstracts and additional conference activities including a BioSkills lab for residents, Tech Talks, and in-booth product demonstrations at AUA2025 will help broaden access to the CVAC System. Read More.
Three new abstracts presented at the European Association of Urology 2025 Annual Meeting (EAU25) underscore the design and resulting efficacy of the CVAC System, outperforming direct-in-scope suction (DISS) in an ex-vivo setting and consistently achieving high stone clearance in a real-world setting. Read More.
The SURE Procedure with the CVAC System delivers 97% stone clearance independent of baseline stone volume Read More.
Multi-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE with CVAC Compared to Standard URS Read More.
Full Launch of CVAC System Announced, Following Successful Early User Evaluation with Physicians Reporting 99% Median Stone Clearance Read More.
New Solution for Kidney Stone Treatment Already Used to Treat More than 50 Patients. Read More.
Investment Round will Fund Expansion of Commercial Team and Further Product Development. Read More.
The CVAC Aspiration System removed 96.1% of the stone volume on average. Read More.
Investment Round will Fund Further Product Development and Expansion of Calyxo’s Team. Read More.
Click on title for full story
CVAC was featured on the front page of the July 2023 edition of AUA News. Dr. Stuart Wolf reflects on his experiences with CVAC from his plenary presentation at AUA 2023. Read More.
MA00051.M